THIOPLAN 15MG

Thioplan 15 mg Injection is classified as an alkylating agent and is utilized to prepare patients for bone marrow transplants while minimizing the risk of graft rejection. Additionally, it is prescribed for the treatment of breast cancer, ovarian cancer, bladder cancer, and neoplastic diseases affecting the serosal cavity. It is also effective in managing malignant effusions resulting from cancerous tumors.

This injection contains Thiotepa, which functions by eliminating bone marrow cells. This process facilitates the transplantation of new bone marrow cells (haematopoietic progenitor cells), allowing the body to generate healthy blood cells. It aids in cancer treatment by inhibiting or halting the proliferation of cancer cells within the body.

Thioplan 15 mg Injection will be administered by a qualified healthcare professional; self-administration is not advised. In certain instances, this injection may lead to side effects such as nausea, vomiting, abdominal pain, decreased appetite, headaches, dizziness, hair loss, unusual fatigue or weakness, and discomfort at the injection site. It is important to consult your doctor if any side effects persist or intensify.

Inform your doctor if you have any allergies to the ingredients in Thioplan 15 mg Injection. This medication should not be used during pregnancy or while breastfeeding. Thioplan 15 mg Injection may result in blurred vision, dizziness, and headaches; therefore, it is advisable to drive or operate machinery only when fully alert. Keep your doctor updated about your health status and any medications you are taking to prevent potential side effects or interactions.